Skip to main content
Sadhana Nitrochem Ltd. logo

Sadhana Nitrochem Ltd. — Investor Relations & Filings

Ticker · SADHNANIQ ISIN · INE888C01040 BSE.NS Manufacturing
Open in API
Filings indexed 835 across all filing types
Latest filing 2025-08-06 Regulatory Filings
Country IN India
Listing BSE.NS SADHNANIQ

About Sadhana Nitrochem Ltd.

https://www.sncl.com

Sadhana Nitrochem Ltd. specializes in the manufacture of chemical intermediates and performance chemicals. The company's core product portfolio includes nitrobenzene and its downstream derivatives such as metanilic acid, aniline 2,5 disulphonic acid, and sodium meta nitrobenzene sulphonate. These products serve as critical raw materials for the global dyes, pigments, pharmaceuticals, and agrochemicals sectors. The company operates advanced manufacturing facilities focused on high-purity chemical synthesis and process optimization. Its technical capabilities extend to specialized chemical reactions including nitration, hydrogenation, and sulfonation. By maintaining a vertically integrated production model, the company ensures consistent quality and supply chain reliability for its international client base across various industrial applications.

Recent filings

Filing Released Lang Actions
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-08-06 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-08-06 English
Sadhana Nitro Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 ,inter alia, to consider and approve SADHANA NITROCHEM LTD. has ....
Regulatory Filings
2025-08-05 English
Board Meeting — Financial Results
Board/Management Information Classification · 95% confidence The document is a formal notice from Sadhana Nitro Chem Limited addressed to stock exchanges (BSE and NSE) informing about an upcoming Board Meeting scheduled for August 12, 2025. The purpose of the meeting includes consideration and approval of the unaudited standalone and consolidated financial results for the quarter ended June 30, 2025. The document also mentions the closure of the trading window for insiders in compliance with SEBI regulations. The document is short (2202 characters) and serves as an announcement of a board meeting and related regulatory compliance, not the financial results report itself. Therefore, it is best classified as Board/Management Information (MANG), which covers announcements of board meetings and related management information.
2025-08-05 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming compliance for the quarter ended June 30, 2025. It includes detailed reconciliation statements and demat/remat requests data for the quarter. The document is a compliance certificate related to share dematerialization and reconciliation, issued by the Registrar and Transfer Agent (RTA) and addressed to stock exchanges and regulatory bodies. It does not contain financial statements, management discussion, or earnings data. It is primarily a regulatory compliance certificate and report, not a financial report or announcement of voting results or capital changes. The document length is about 13,819 characters, indicating it is a full certificate and report, not a brief announcement. Therefore, the most appropriate classification is Regulatory Filings (RNS), as it is a regulatory compliance certificate and report that does not fit into other specific categories like Annual Report, Earnings Release, or Capital Update.
2025-07-23 English
Certificate under Reg. 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30 June, 2025
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming compliance for the quarter ended June 30, 2025. It includes detailed reconciliation statements and demat/remat requests data for the quarter. The document is a compliance certificate related to share dematerialization and reconciliation, issued by the Registrar and Transfer Agent (RTA) and addressed to stock exchanges and regulatory bodies. It does not contain financial statements or management discussion but is a regulatory compliance certificate. Therefore, it fits best under Regulatory Filings (RNS) as it is a regulatory compliance certificate and not a financial report or announcement of a report.
2025-07-23 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.